Ulipristal
- Generic Name
- Ulipristal
- Brand Names
- Ella, Ellaone, Esmya, ellaOne
- Drug Type
- Small Molecule
- Chemical Formula
- C28H35NO3
- CAS Number
- 159811-51-5
- Unique Ingredient Identifier
- 6J5J15Q2X8
- Background
Ulipristal is a selective progesterone receptor modulator used for the purposes of emergency contraception (Ella) and for the treatment of uterine fibroids (Fibristal). It is a derivative of 19-norprogesterone and has both antagonistic and partial agonist activity at the progesterone receptor. It also binds to glucocorticoid receptor, however compared to mif...
- Indication
As the product Ella (available in Canada and the US), ulipristal is indicated for use as emergency contraception after unprotected intercourse or possible contraceptive failure when administered within 120 hours (5 days) after unprotected intercourse or a known or suspected contraceptive failure. As the product Fibristal (available in Canada), ulipristal is ...
- Associated Conditions
- Moderate Uterine Fibroids, Severe Uterine Fibroids
- Associated Therapies
- Emergency Contraception
Global Rx-to-OTC Switches Market Set to Reach USD 66.5 Billion by 2033
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.